Loading
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for MASIMO CORP.
Filing timeline
BuySaleMichelle Brennan
Insider track record
Disclosed buys
10
Disclosed sells
0
Signal history
Closed purchases
Market purchases
10
Positive at T+90
100%
Median T+90
+2.6%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +35.0%Entry US$76.58 · Close at T+365 US$103.39
- +39.4%Entry US$75.27 · Close at T+365 US$104.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michelle Brennan: trading record in brief
Michelle Brennan appears in 24 filings at three US companies, always as Director: Coupa Software Inc (9 filings), Cardinal Health Inc (8) and Masimo Corp (7). They were published from December 23, 2020 to June 12, 2026.
This record stands out for its purchases: 10 purchases, with no sale, for EUR 123,578, with a median of EUR 12,407, so the amounts are modest. The three largest are EUR 18,069 at Coupa Software (March 16, 2022), EUR 14,775 at Cardinal Health (November 14, 2022) and EUR 14,482 at Masimo (November 15, 2022). Five of the ten purchases concern Coupa Software. On top of that come 7 grants, 4 option exercises and 3 filings of another nature.
Activity ranges from 1 to 8 filings a year, with 8 in 2022 and 6 in 2025. The 2 filings of the last twelve months are neither purchases nor sales. Publication arrives a median of 2 days after the trade.
Companies and markets linked to Michelle Brennan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
9,309 sharesCommon StockSEC:0001104659-26-073526:0
1,067 shares0Common SharesSEC:0001827353-25-000003:0
100 shares@ US$155.251.5% of flowCommon StockSEC:0000937556-25-000125:1
Canonical exit: 11 Nov 2025 (T+90)
100 shares@ US$150.35100.0% of flowCommon StockSEC:0000937556-25-000125:0
Canonical exit: 10 Nov 2025 (T+90)
1,790 shares0Common StockSEC:0000937556-25-000066:0
4,816 shares@ US$179.5197.0% of flowCommon StockSEC:0000937556-25-000020:1
8,916 shares0Common StockSEC:0000937556-25-000020:0
1,730 shares0Common SharesSEC:0000721371-24-000151:0
1,228 shares0Common StockSEC:0000937556-24-000078:0
1,965 shares0Common SharesSEC:0000721371-23-000109:0
1,038 sharesCommon StockSEC:0000899243-23-006443:1
804 sharesCommon StockSEC:0000899243-23-006443:0
200 shares@ US$74.7235.2% of flowCommon SharesSEC:0000721371-22-000170:1
Canonical exit: 13 Feb 2023 (T+90)
200 shares@ US$76.30100.0% of flowCommon SharesSEC:0000721371-22-000170:0
Canonical exit: 12 Feb 2023 (T+90)
150 shares@ US$79.7429.0% of flowCommon SharesSEC:0000721371-22-000164:1
Canonical exit: 8 Feb 2023 (T+90)
2,308 shares0Common SharesSEC:0000721371-22-000164:0
466 shares0Common SharesSEC:0000721371-22-000118:0
804 shares0Common StockSEC:0001214659-22-007519:0
125 shares@ US$77.4015.7% of flowCommon StockSEC:0001214659-22-004139:1
Canonical exit: 14 Jun 2022 (T+90)
250 shares@ US$79.28100.0% of flowCommon StockSEC:0001214659-22-004139:0
Canonical exit: 14 Jun 2022 (T+90)
413 shares0Common StockSEC:0001214659-21-006077:0
30 shares@ US$353.8818.3% of flowCommon StockSEC:0001214659-20-010648:0
Canonical exit: 21 Mar 2021 (T+90)
30 shares@ US$360.5918.6% of flowCommon StockSEC:0001214659-20-010648:1
Canonical exit: 22 Mar 2021 (T+90)
40 shares@ US$360.5725.0% of flowCommon StockSEC:0001214659-20-010648:2
Canonical exit: 23 Mar 2021 (T+90)
24 of 24 declarations
